---
{"dg-publish":true,"permalink":"/research/insights/2025-01-30-15-34-35/","updated":"2025-01-30T15:34:35-05:00"}
---

# Content
- [[Research/Tags/Urolithin A\|Urolithin A]] slows the progression of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A
# References
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">5</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-37-02.md" data-href="Research/Insights/2025-01-30 15-37-02.md" href="Research/Insights/2025-01-30 15-37-02.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-37-02</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the reduction in <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> histological score at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-32-27.md" data-href="Research/Insights/2025-01-30 15-32-27.md" href="Research/Insights/2025-01-30 15-32-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-32-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression in <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Pfirrmann Grade" href="Pfirrmann Grade" class="internal-link" target="_blank" rel="noopener nofollow">Pfirrmann Grade</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-17-08.md" data-href="Research/Insights/2025-01-30 15-17-08.md" href="Research/Insights/2025-01-30 15-17-08.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-17-08</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> disc height index at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-15-20.md" data-href="Research/Insights/2025-01-30 15-15-20.md" href="Research/Insights/2025-01-30 15-15-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-15-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Collagen Type II" href="Collagen Type II" class="internal-link" target="_blank" rel="noopener nofollow">Collagen Type II</a> fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-14-32.md" data-href="Research/Insights/2025-01-30 15-14-32.md" href="Research/Insights/2025-01-30 15-14-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-14-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Aggrecan" href="Aggrecan" class="internal-link" target="_blank" rel="noopener nofollow">Aggrecan</a> fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Original Sources</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span>Citations</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" data-href="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" href="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">shiUrolithinAlleviatesOxidative2021</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Shi, Peng-Zhi, Jun-Wu Wang, Ping-Chuan Wang, Bo Han, Xu-Hua Lu, Yong-Xin Ren, Xin-Min Feng, Xiao-Fei Cheng, and Liang Zhang. “Urolithin a Alleviates Oxidative Stress-Induced Senescence in Nucleus Pulposus-Derived Mesenchymal Stem Cells through SIRT1/PGC-1α Pathway.” World Journal of Stem Cells 13, no. 12 (December 26, 2021): 1928–46. <a rel="noopener nofollow" class="external-link" href="https://doi.org/10.4252/wjsc.v13.i12.1928" target="_blank">https://doi.org/10.4252/wjsc.v13.i12.1928</a>.</span></td></tr></tbody></table></div>

